The Cytotoxic Effect of Polygonium cognatum and Chemotherapeutic Effect of Doxorubicin on Glioblastoma Cells
Abstract views: 174 / PDF downloads: 72
Keywords:Glioblastoma, P. cognatum, doxorubicin
Objective: Glioblastoma multiforme (GBM) is an aggressive malignant brain tumor common in adults. Owing to the present difficulty in treating GBM, developing alternative methods is of utmost importance. Recently, the efficacy of various plant extracts in cancer treatment have been evaluated. Polygonum cognatum (P. cognatum) known as ‘Madımak’ is used in herbal medicine in Turkey. Methods: In this study, we investigated the cytotoxity of P. cognatum in the treatment of glioblastoma and its contribution to the effectiveness of doxorubicin (DXR). In the U87 cell line of the P. cognatum and doxorubicin administered at different doses, IC50 doses were determined using the 2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide (XTT) method and the effects of combined administration at these doses were examined (respectively 10–125 µg/ml and 0.1–10 µg/ml at 24, 48, and 72 h). Results: P. cognatum extract decreased the cell viability of U87 cells in a time and concentration-dependent manner. It also increased the apoptotic effectiveness of DXR in U87 cells. Conclusion: This is the first preliminary study that investigates the treatment of P. cognatum on glioblastoma in vitro. Further studies are required to investigate the effect of the extract on healthy human cells and to understand signaling pathways.
Urbańska K, Sokołowska J, Szmidt M, Sysa P. Glioblastoma multiforme - an overview. Contemp Oncol 2014; 18: 307-12. https://doi.org/10.5114/wo.2014.40559
Zhang P, Sun S, Li N, Ho A, Kiang K, Zhang X, et al. Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition. J Neurooncol 2017; 132: 393-400. https://doi.org/10.1007/s11060-017-2387-y
Malinovskaya Y, Melnikov P, Baklaushe, V, Gabashvili A, Osipova N, Mantrov S, et al. Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells. Int J Pharm 2017; 524: 77‐90. https://doi.org/10.1016/j.ijpharm.2017.03.049
Ngulde SI, Sandabe UK, Abounader R, Dawson TK, Zhang Y, Iliya I, et al. Ethanol Extract of Securidaca longipedunculata Induces Apoptosis in Brain Tumor (U87) Cells. Biomed Res Int 2019; 2019: 1-5. https://doi.org/10.1155/2019/9826590
Rivankar S. An overview of doxorubicin formulations in cancer therapy. J Cancer Res Ther 2014; 10: 853-8. https://doi.org/10.4103/0973-1482.139267
Yang F, Teves SS, Kemp CJ, Henikoff S. Doxorubicin, DNA torsion, and chromatin dynamics. Biochim Biophys Acta 2014; 1845: 84-9. https://doi.org/10.1016/j.bbcan.2013.12.002
Hau P, Fabel K, Baumgart U, Rümmele P, Grauer O, Bock A, et al. Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer 2004; 100: 1199-207. https://doi.org/10.1002/cncr.20073
Zou D, Wang W, Lei D, Yin Y, Ren P, Chen J, et al. Penetration of blood-brain bar-rier and antitumor activity and nerve repair in glioma by doxorubicin loaded monosialoganglioside micelles system. Int J Nanomedicine 2017; 12: 4879-89. https://doi.org/10.2147/IJN.S138257
Meng L, Chu X, Xing H, Liu X, Xin X, Chen L, et al. Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol. Int J Pharm 2019; 567: 118485. https://doi.org/10.1016/j.ijpharm.2019.118485
Adem FA, Mbaveng AT, Kuete V, Heydenreich M, Ndakala A, Irungu B, et al. Cytotoxicity of isoflavones and biflavonoids from Ormocarpum kirkii towards multi-factorial drug resistant cancer. Phytomedicine 2019; 58: 152853. https://doi.org/10.1016/j.phymed.2019.152853
Rezadoost MH, Kumleh HH, Ghasempour A. Cytotoxicity and apoptosis induction in breast cancer, skin cancer and glioblastoma cells by plant extracts. Mol Biol Rep 2019; 46: 5131-42. https://doi.org/10.1007/s11033-019-04970-w
Mulpur BH, Nabors LB, Thompson RC, Olson JJ, LaRocca RV, Thompson Z, et al. Complementary therapy and survival in glioblastoma. Neurooncol Pract 2015; 2: 122-6. https://doi.org/10.1093/nop/npv008
Önen H, Altuntaş E, Özgöz E, Bayram M, Özcan S. Moisture effect on physical properties of knotweed (Polygonum cognatum Meissn.) seeds. Journal of Agricultural Faculty of Gaziosmanpasa University 2014; 31: 15-24. https://doi.org/10.13002/jafag670
Baytop T. Therapy with Medicinal Plants in Turkey Past and Present. 2th ed. Istanbul: Nobel Tip Kitabevi;1999.
Kanthal L, Dey A, Satyavathi K, Bhojaraju P. GC-MS analysis of bioactive compounds in methanolic extract of Lactuca runcinata DC. Pharmacognosy Res 2014; 6: 58-61. https://doi.org/10.4103/0974-8490.122919
Yool AJ, Ramesh S. Molecular Targets for Combined Therapeutic Strategies to Limit Glioblastoma Cell Migration and Invasion. Front Pharmacol 2020; 11: 1-26. https://doi.org/10.3389/fphar.2020.00358
Carter TC, Medina-Flores R, Lawler BE. Glioblastoma Treatment with Temozolomide and Bevacizumab and Overall Survival in a Rural Tertiary Healthcare Practice. Biomed Res Int 2018; 6204676: 1-10. https://doi.org/10.1155/2018/6204676
Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-96. https://doi.org/10.1056/NEJMoa043330
Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352: 997-1003. https://doi.org/10.1056/NEJMoa043331
Ramirez Y, Weatherbee J, Wheelhouse R, Ross A. Glioblastoma Multiforme Therapy and Mechanisms of Resistance. Pharmaceuticals 2013; 6: 1475-506. https://doi.org/10.3390/ph6121475
Eom YW, Kim MA, Park SXS, Goo MJ, Kwon HJ, Sohn S, et al. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 2005; 24: 4765-77. https://doi.org/10.1038/sj.onc.1208627
Lesniak MS, Upadhyay U, Goodwin R, Tyler B, Brem H. Local delivery of doxorubicin for the treatment of malignant brain tumors in rats. Anticancer Res 2005; 25: 3825-31.
Hui A, Prakash O. Doxorubicin Response to Temozolomide-resistant Brain Cancer Glioblastoma Cells. Louisiana Cancer Research Consortium, New Orleans. 2015. Available from: https://www.medschool.lsuhsc.edu/cancer_center/docs/Hui%2036x60%20-%20Closing%20Poster%20(STREC2015).pdf
Wang CW, Chen CL, Wang CK, Chang YJ, Jian JY, Lin CS, et al. Cisplatin-, doxorubicin-, and docetaxel-induced cell death promoted by the aqueous extract of solanum nigrum in human ovarian carcinoma cells. Integr Cancer Ther 2015; 14: 546-55. https://doi.org/10.1177/1534735415588826
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.